MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

OvaScience Company Profile (NASDAQ:OVAS)

Consensus Ratings for OvaScience (NASDAQ:OVAS) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $12.37 (121.61% upside)

Analysts' Ratings History for OvaScience (NASDAQ:OVAS)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2016Leerink SwannReiterated RatingHold$6.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016Oppenheimer Holdings Inc.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/25/2016Credit Suisse Group AGReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016S&P Equity ResearchLower Price Target$10.82 -> $8.83View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016HC WainwrightReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2015WedbushLower Price TargetOutperform$46.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015JMP SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015JPMorgan Chase & Co.Initiated CoverageNeutral$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/2/2014 forward)
Earnings History for OvaScience (NASDAQ:OVAS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q116($0.72)($0.80)$0.14 million$0.15 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q315($0.71)($0.76)$0.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q3($0.68)($0.66)$0.17 million$0.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.64)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015($0.65)($0.65)$0.40 million$0.02 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.59)($0.79)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.44)($0.54)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.45)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014($0.46)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.39)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2013Q313($0.35)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2013Q213($0.28)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for OvaScience (NASDAQ:OVAS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.81)($0.81)($0.81)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.70)($0.70)($0.70)
(Data provided by Zacks Investment Research)
Dividend History for OvaScience (NASDAQ:OVAS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for OvaScience (NASDAQ:OVAS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/1/2016Michelle DippCEOBuy425,000$7.00$2,975,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Michelle DippCEOBuy20,000$7.86$157,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Michelle DippCEOBuy40,000$7.63$305,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Richard AldrichDirectorBuy36,095$6.94$250,499.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Richard AldrichDirectorBuy20,000$7.64$152,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Michelle DippCEOBuy19,900$7.72$153,628.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Paul W.D. ChapmanCOOBuy3,100$7.37$22,847.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2016Michelle DippCEOBuy59,800$9.49$567,502.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2016Michelle DippCEOBuy59,800$10.44$624,312.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Michelle DippCEOBuy59,700$8.26$493,122.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Michelle DippCEOBuy59,029$7.90$466,329.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Michelle DippCEOBuy162,732$7.60$1,236,763.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Jeffrey E YoungCFOBuy3,450$10.70$36,915.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Marc D KozinDirectorBuy4,800$10.79$51,792.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Mary FisherDirectorBuy6,100$16.49$100,589.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Marc D KozinDirectorBuy3,000$17.60$52,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Marc D KozinDirectorBuy3,000$28.45$85,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Michelle DippCEOBuy1,000$32.49$32,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2015Thomas MalleyDirectorBuy35,000$50.00$1,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Richard AldrichDirectorBuy2,000$9.49$18,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Richard AldrichDirectorBuy2,000$9.16$18,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Richard AldrichDirectorBuy2,000$8.81$17,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Richard AldrichDirectorBuy2,000$8.52$17,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Richard AldrichDirectorBuy2,000$7.59$15,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2014Harald F StockDirectorBuy1,063$7.01$7,451.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Richard AldrichDirectorBuy2,000$7.29$14,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2014Richard AldrichDirectorBuy2,000$7.50$15,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2014Harald F StockDirectorBuy1,050$7.13$7,486.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Richard AldrichDirectorBuy2,000$7.33$14,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Fund L.P. LongwoodMajor ShareholderBuy100,000$10.00$1,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Arthur TzianabosInsiderBuy1,000$10.32$10,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Harald F StockDirectorBuy4,500$10.64$47,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Christopher A BleckInsiderBuy2,000$11.15$22,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Richard AldrichDirectorBuy4,850$10.54$51,119.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for OvaScience (NASDAQ:OVAS)
DateHeadline
07/01/16 08:27 AMRecently Issued Stock Ratings For Ovascience Inc. (OVAS) - Fiscal Standard
07/01/16 07:19 AMOVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/01/16 06:10 AM7:10 am OvaScience announces Dr. Harald Stock has officially succeeded co-founder Michelle Dipp as CEO, completing the planned leadership transition from CEO-elect -
07/01/16 06:00 AMHarald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald F. Stock, Ph.D., has officially assumed the role of President and Chief Executive Officer, completing a planned leadership transition from Chief Executive Officer-Elect.
06/29/16 05:36 PMCan OvaScience Inc's Tomorrow Be Different? The Stock Increases Again - Engelwood Daily
06/29/16 05:36 PMOvaScience Inc. (OVAS) Jumps 11.97% on June 28 - Equities.com
06/28/16 05:38 PMCheck on Share Volatility: OvaScience, Inc. (NASDAQ:OVAS) - Engelwood Daily
06/28/16 05:38 PMOvaScience Inc (NASDAQ:OVAS)'s Company Shares Decreased 31.01% After High Volatility - Engelwood Daily
06/28/16 10:33 AMWhat Investors are Making of These Biotech Stocks? - ChemoCentryx, Alder Biopharma, Neothetics, and OvaScience
06/26/16 10:13 AMOvaScience : El Pasoan a star in biotech industry
06/25/16 05:11 PMHow Many OvaScience Inc (NASDAQ:OVAS)'s Analysts Are Bearish? - Engelwood Daily
06/24/16 08:17 AMOvascience Inc. (NASDAQ:OVAS) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 06:15 PMThe 2016 Report on In- Vitro Fertilization (IVF) World Market Segmentation and 10 Major Manufacturers Analysis
06/23/16 08:21 AMOvaScience, Inc. (NasdaqGM:OVAS) Stock Momentum Hits EXTREME Weakness - CML News
06/22/16 05:35 PMStrong Buy Calls Count For Ovascience Inc. (NASDAQ:OVAS) At 2 - Investor Newswire
06/22/16 05:35 PMOvaScience, Inc. (NASDAQ:OVAS) headlining after earnings - iStreetWire
06/20/16 07:18 AMOvascience Inc. (OVAS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 07:00 AMOvaScience to Present at the JMP Securities Life Sciences Conference - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the JMP Securities Life Sciences Conference on Tuesday, June 21, 2016 at 11:30 am ET at the St.
06/16/16 05:56 PMLearn details of the World in vitro fertilization devices & consumables market to grow at a CAGR of 19.7%
06/13/16 08:40 AMEarnings Trend per share for Investors: Seattle Genetics, Inc. (NASDAQ:SGEN), OvaScience, Inc. (NASDAQ:OVAS) - Beacon Chronicle
06/13/16 08:40 AMLast Traded Price Fluctuations: Quest Diagnostics Incorporated (NYSE:DGX) , Ovascience Inc. (NASDAQ:OVAS) - Street Updates
06/10/16 05:59 PMOvaScience Inc. (OVAS) Drops 9.33% on June 09 - Equities.com
06/10/16 08:40 AMTwo Stocks within Traders Observation: Skyline Medical Inc. (NASDAQ:SKLN) , Ovascience Inc. (NASDAQ:OVAS) - Street Updates
06/08/16 06:08 PMOVASCIENCE INC. (NASDAQ:OVAS) Financial Condition Compared to S&P 500 - CML News
06/07/16 08:26 AMForm 4 OvaScience, Inc. For: Jun 02 Filed by: CAPELLO JEFFREY D - StreetInsider.com
06/07/16 08:26 AMStocks inside Investors Spotlight: Centene Corporation (NYSE:CNC) , Ovascience Inc. (NASDAQ:OVAS) - Street Updates
06/06/16 05:38 PMForm 4 OvaScience, Inc. For: Jun 02 Filed by: FISHER MARY - StreetInsider.com
06/06/16 09:24 AMForm 4 OvaScience, Inc. For: Jun 02 Filed by: HOWE JOHN P MD - StreetInsider.com
06/05/16 05:43 PMAfter Last Week What Do Analysts Think Of Ovascience Inc. (OVAS) - Share Trading News
06/04/16 08:36 AMOvaScience Inc (OVAS) CEO Michelle Dipp Purchases 425000 Shares - Let Me Know About This
06/03/16 03:21 PMOVASCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 03:05 PMOvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the grant of an inducement award to its newly appointed Executive Vice President, Human Resources, Toni Spinazzola.
06/03/16 08:35 AMBrokerages gives Consensus Recommendation of “Hold” to OvaScience Inc (NASDAQ:OVAS) - Let Me Know About This - Brokerages gives Consensus Recommendation of “Hold” to OvaScience Inc (NASDAQ:OVAS)Let Me Know About ThisOvaScience logo OvaScience Inc (NASDAQ:OVAS) has received an average rating of “Hold” from the nine brokerages that are presently covering the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating ...Buy, Sell Or Hold Rating For Ovascience Inc. (OVAS)?Share Trading NewsOvaScience Announces Closing of Public Offering of Common StockBusiness Wire (press release)all 4 news articles »
06/02/16 06:05 PMBuy, Sell Or Hold Rating For Ovascience Inc. (OVAS)? - Share Trading News - Buy, Sell Or Hold Rating For Ovascience Inc. (OVAS)?Share Trading News05/06/2016 – Ovascience Inc. had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 7 price target on the stock. 03/24/2016 – Ovascience Inc. had its “underperform” rating reiterated by analysts at Credit Suisse.OvaScience Announces Closing of Public Offering of Common StockBusiness Wire (press release)all 5 news articles »
06/02/16 08:39 AMInsiders Are Gradually Buying OvaScience, Inc. (NASDAQ:OVAS) - HNN - Insiders Are Gradually Buying OvaScience, Inc. (NASDAQ:OVAS)HNNAccording to the latest SEC filings, insiders at OvaScience, Inc. (NASDAQ:OVAS) have increased their position in the stock by 72.17% over the past 6 months. Insiders now own 7.60% of total outstanding shares. There are both legal and illegal types of ...and more »
06/02/16 08:39 AMStocks Earnings Analysis Report: OvaScience, Inc. (NASDAQ:OVAS), Nielsen Holdings plc (NYSE:NLSN) - Beacon Chronicle - Beacon ChronicleStocks Earnings Analysis Report: OvaScience, Inc. (NASDAQ:OVAS), Nielsen Holdings plc (NYSE:NLSN)Beacon ChronicleLast Trade: The Company closed its last session at $53.39 with the loss of -0.04%. The market capitalization of the company is $19.13 Billion, with the average Volume of 1.86 Million. The stock currently has its 52-Week High range of $54.59 and 52-week ...and more »
06/01/16 06:10 PMOvaScience Announces Closing of Public Offering of Common Stock - Business Wire (press release) - OvaScience Announces Closing of Public Offering of Common StockBusiness Wire (press release)WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the closing of its previously announced public ...and more »
06/01/16 03:05 PMOvaScience Announces Closing of Public Offering of Common Stock - [Business Wire] - OvaScienceSM , a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the closing of its previously announced public offering, including the exercise in full by the underwriters of their option to purchase an additional 1,072,500 shares of common stock at the public offering price of $7.00 per share.
06/01/16 08:38 AMHealthcare Stocks in Target: Relypsa, Inc. (NASDAQ:RLYP) , Ovascience Inc. (NASDAQ:OVAS) - Is stories - Is storiesHealthcare Stocks in Target: Relypsa, Inc. (NASDAQ:RLYP) , Ovascience Inc. (NASDAQ:OVAS)Is storiesRelypsa, Inc. (NASDAQ:RLYP) increased +5.76% to $19.10 while traded 6.96 million shares on 5/31/2016. The stock price negotiated for value between $18.20 to $19.32 in recent trading session. During the past 52 weeks, the stock's price witnessed a ...and more »
05/31/16 05:59 PMOvascience Inc. (NASDAQ:OVAS) Stock Update & Estimates - Stock Tick Tock - Ovascience Inc. (NASDAQ:OVAS) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Ovascience Inc. (NASDAQ:OVAS) to post earnings of $-0.82 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued around ...and more »
05/31/16 05:59 PMOvaScience Inc. (OVAS) Jumps 7.1% on May 31 - Equities.com - OvaScience Inc. (OVAS) Jumps 7.1% on May 31Equities.comOvaScience Inc. (OVAS) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 7.1% to $7.39, representing a gain of $0.49 per share. Some 1.72 million shares traded hands on 8,610 trades, compared with an average ...and more »
05/31/16 10:38 AMHC Stocks Watchful: Molina Healthcare, Inc. (NYSE:MOH), OvaScience Inc (NASDAQ:OVAS) - share market updates (press release) - HC Stocks Watchful: Molina Healthcare, Inc. (NYSE:MOH), OvaScience Inc (NASDAQ:OVAS)share market updates (press release)Shares of Molina Healthcare, Inc. (NYSE:MOH) ended Friday session in green amid volatile trading. The shares closed up +0.67 points or 1.40% at $48.56 with 831,344.00 shares getting traded. Post opening the session at $48.03, the shares hit an intraday ...and more »
05/31/16 10:38 AMOverview of Price Moves: Ovascience Inc. (NASDAQ:OVAS) , Align Technology, Inc. (NASDAQ:ALGN) - Street Updates - Overview of Price Moves: Ovascience Inc. (NASDAQ:OVAS) , Align Technology, Inc. (NASDAQ:ALGN)Street UpdatesOvascience Inc. (NASDAQ:OVAS) diminished -0.43%, closing at $6.90 after floating between $6.70 and $7.06. The company has market capitalization of $188.56M. It has twelve month low of $4.53 and twelve month high of $39.29. The recent traded volume ...and more »
05/30/16 01:47 PMOvaScience Inc (OVAS) Given Hold Rating at Leerink Swann - Let Me Know About This - OvaScience Inc (OVAS) Given Hold Rating at Leerink SwannLet Me Know About ThisOvaScience logo OvaScience Inc (NASDAQ:OVAS)'s stock had its “hold” rating reiterated by equities research analysts at Leerink Swann in a research report issued to clients and investors on Sunday. They currently have a $7.00 price objective on the ...Ovascience Incorporated (NASDAQ:OVAS) Sellers Increased By 1.69% Their ShortsThe PostOvascience Inc. (OVAS) Broker Price Targets For The Coming WeekShare Trading Newsall 2 news articles »
05/28/16 11:52 AMMoving Healthcare Focused Stocks: Ovascience Inc. (NASDAQ:OVAS) , Pacific Biosciences of California, Inc ... - Is stories - Is storiesMoving Healthcare Focused Stocks: Ovascience Inc. (NASDAQ:OVAS) , Pacific Biosciences of California, Inc ...Is storiesOvascience Inc. (NASDAQ:OVAS) decreased -29.14% to $6.93 while traded 4.75 million shares on 5/26/2016. The stock price negotiated for value between $6.77 to $7.58 in recent trading session. During the past 52 weeks, the stock's price witnessed a ...Biotech Laggards: OvaScience, (NASDAQ:OVAS), Pacific Biosciences of California, Inc. (NASDAQ:PACB), PTC ...Benchmark Monitorall 7 news articles »
05/28/16 11:52 AMOvaScience Inc. (OVAS) Drops 29.14% on May 26 - Equities.com - OvaScience Inc. (OVAS) Drops 29.14% on May 26Equities.comOvaScience Inc. (OVAS) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 29.14% to $6.93, a loss of $-2.85 per share. Starting at an opening price of $7.37 a share, the stock traded between $6.77 and $7.58 over the ...and more »
05/27/16 12:56 PMMid-Day Market Update: Dollar Tree Surges Following Earnings Beat; OvaScience Shares Drop - Nasdaq - Mid-Day Market Update: Dollar Tree Surges Following Earnings Beat; OvaScience Shares DropNasdaqMinerva Neurosciences Inc (NASDAQ: NERV ) shares shot up 158 percent to $9.15 after the company revealed positive top line results from a prospective Phase IIb, 12-week, randomized, double-blind, placebo-controlled parallel clinical study evaluating ...Mid-Morning Market Update: Markets Mostly Flat; Dollar General Profit Beats ExpectationsBenzingaall 5 news articles »
05/27/16 12:56 PMHealthcare Losers Standing on Selling Boundary- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), OvaScience, Inc ... - Seneca Globe - Franklin IndependentHealthcare Losers Standing on Selling Boundary- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), OvaScience, Inc ...Seneca GlobeIonis Pharmaceuticals, Inc. (NASDAQ:IONS) [Trend Analysis] shows fluctuation in active trade, on Friday shares jumped down -39.42% to $21.36. Ionis Pharmaceuticals' (IONS) partner GlaxoSmithKline (GSK) decided against beginning a phase-three study ...Morning Movers: OvaScience, Inc. (NASDAQ:OVAS), Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), WebMD Health ...Benchmark MonitorUnusual 11 Mid-Day Movers 5/26: (NERV) (FLXN) (SKIS) Higher; (IONS) (PRGN) (TDW) LowerStreetInsider.comall 72 news articles »
05/27/16 12:56 PMMid-day Market Update: OvaScience Inc (NASDAQ:OVAS) - The Point Review - The Point ReviewMid-day Market Update: OvaScience Inc (NASDAQ:OVAS)The Point ReviewShare of OvaScience Inc (NASDAQ:OVAS) traded on -29.19 percent below secure line at 2:09PM EDT in order to take the company's stock at the price of $6.93. At the time of writing the stock exchanged hands 3.95 million shares versus average trading ...Stock Update (NASDAQ:OVAS): OvaScience Inc Announces Pricing of Public Offering of Common StockSmarter AnalystCurrent Price Targets For Ovascience Inc. (OVAS)Risers & FallersShould OvaScience Inc. (NASDAQ: OVAS) Shareholders Be Worried?Scibility MediaStreet Updates -Insider Monkey (blog) -Benchmark Monitorall 26 news articles »
05/26/16 10:05 AMOvaScience Prices Secondary Offering -
About OvaScience

OvaScience logoOvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's own ovarian tissue. The Company's AUGMENT treatment is designed to improve egg health by supplementing a mitochondrial deficiency. With the AUGMENT treatment, energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs during the in vitro fertilization process to supplement the existing mitochondria. Its OvaPrime treatment is a fertility treatment designed to replenish a woman's ovary by increasing her egg reserve using her own EggPC cells. Its OvaTure treatment is a fertility treatment that seeks to create mature fertilizable eggs in vitro from a woman's own EggPC cells without the need for hormone hyperstimulation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OVAS
  • CUSIP:
Key Metrics:
  • Previous Close: $5.58
  • 50 Day Moving Average: $6.64
  • 200 Day Moving Average: $7.78
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $152.49M
  • Current Quarter EPS Consensus Estimate: $-3.14 EPS
Additional Links:
OvaScience (NASDAQ:OVAS) Chart for Saturday, July, 2, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha